
Leonhardt Ventures Introduces E-Stent™ Bioelectric Platform for Regenerative Medicine
Leonhardt Ventures has unveiled the E-Stent™, a wireless bioelectric stimulation stent technology that can control protein expressions for tissue regeneration across 29 medical applications, representing a significant advancement in targeted regenerative therapies.
Read full story



























